CGC
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (May 4th, 2019)
An Interesting Interview with the CFO of TGOD Bottom Line: Some very interesting information came out in this interview…
Canopy Growth Acquires German Cannabinoid Pharmaceutical Company
In another move toward a significantly increased international presence, Canopy Growth Corporation (TSX:WEED; NYSE:CGC) today announced the acquisition of German…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (April 27th, 2019)
The 17 Edible Products Coming to Canada Later This Year Bottom Line: The release of edibles should help reenergize…
Canopy Growth Teams Up With Arthritis Society For Education Initiatives
On the lookout for potential new medical cannabis patients, Canopy Growth Corporation (TSX: WEED; NYSE: CGC) today announced a partnership with…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (April 20th, 2019)
A weekly review of the most important cannabis news to impact your portfolio; from the Canopy acquisition of Acreage to…
Canopy Growth Confirms Bid to Acquire Acreage After U.S. Legalization
After the rumour mill started swirling yesterday about impending news of an acquisition, Canopy Growth Corporation (TSX: WEED; NYSE: CGC) today…
Canopy Growth Acquires Spanish Licensed Cannabis Producer Cafina
Continuing a string of international purchases and expansions, Canopy Growth Corporation (TSX:WEED; NYSE:CGC) just acquired a licensed cannabis company located in Alicante,…
Aphria Q3 2019 Earnings Review – Headlines Create Opportunity
Aphria (TSE: APHA) posted messy quarterly results but remains an undervalued name with big revenue potential later in 2019.
Organigram 2Q 2019 Earnings Review – Selling Cannabis Customers Want
Organigram (CVE: OGI) posted another strong quarter. As a smaller producer, their cannabis production capabilities are impressive and undervalued.